Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
Scientific Reports|February 24, 2017
Relapsing-remitting multiple sclerosis patients display an altered lipoprotein profile with dysfunctional HDLWinde Jorissen, Elien Wouters, Jeroen F Bogie, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2020
Oncostatin M-induced astrocytic tissue inhibitor of metalloproteinases-1 drives remyelinationEvelien Houben, Kris Janssens, Doryssa Hermans, et al.
Journal of Alzheimer'S Disease : JAD|December 16, 2010
Apolipoprotein CI knock-out mice display impaired memory functionsJimmy F P Berbée, Tim Vanmierlo, Karlygash Abildayeva, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|November 4, 2025
Prophylactic PDE4 and PDE4B inhibition reduce lesion size and neutrophil infiltration following ischemic stroke in male miceLaura Ponsaerts, Lotte Alders, Melissa Schepers, et al.
Acta Neuropathologica Communications|June 9, 2021
CSF1R inhibition rescues tau pathology and neurodegeneration in an A/T/N model with combined AD pathologies, while preserving plaque associated microgliaChritica Lodder, Isabelle Scheyltjens, Ilie Cosmin Stancu, et al.
Journal of Neuroinflammation|November 6, 2021
Carnosine quenches the reactive carbonyl acrolein in the central nervous system and attenuates autoimmune neuroinflammationJan Spaas, Wouter M A Franssen, Charly Keytsman, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 17, 2025
Phosphodiesterase 4D inhibition improves the functional and molecular outcome in a mouse and human model of Charcot Marie Tooth disease 1 AMelissa Schepers, Tim Vangansewinkel, Karen Libberecht, et al.
Neurobiology of Aging|August 14, 2009
Liver X receptor activation restores memory in aged AD mice without reducing amyloidTim Vanmierlo, Kris Rutten, Jos Dederen, et al.
Pageof 11